scholarly article | Q13442814 |
P356 | DOI | 10.1097/00006454-199411000-00009 |
P698 | PubMed publication ID | 7845752 |
P2093 | author name string | J D Mathews | |
A J Leach | |||
V Asche | |||
J B Boswell | |||
T G Nienhuys | |||
P433 | issue | 11 | |
P304 | page(s) | 983-989 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants | |
P478 | volume | 13 |
Q28729014 | A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border |
Q33802029 | A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study |
Q35004975 | A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. |
Q33801670 | Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles |
Q30493333 | Absent otoacoustic emissions predict otitis media in young Aboriginal children: a birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia |
Q37644655 | Acute and chronic otitis media |
Q95818833 | Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study |
Q61813662 | Acute otitis media and sociomedical risk factors among unselected children in Greenland |
Q37111789 | Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention |
Q39823299 | Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla |
Q37353506 | Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia. |
Q36618763 | An overview of acute otitis media in Australian Aboriginal children living in remote communities |
Q73957315 | Analysis of isolates recovered from multiple sites of the nasopharynx of children colonized by nontypeable Haemophilus influenzae |
Q34110986 | Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. |
Q36369062 | Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial |
Q38614685 | Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. |
Q24243309 | Antibiotics for persistent nasal discharge (rhinosinusitis) in children |
Q24244439 | Antibiotics for persistent nasal discharge (rhinosinusitis) in children |
Q24243776 | Antibiotics for the prevention of acute and chronic suppurative otitis media in children |
Q24248123 | Antibiotics for the prevention of acute otitis media in children |
Q34005904 | Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains |
Q43686522 | Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae in healthy carriers: report of a study in 5-year-olds in Marcory, Abidjan, Côte d'Ivoire |
Q34519235 | Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia: a cohort study |
Q38984614 | Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens |
Q64098314 | Australian Aboriginal children have higher hospitalization rates for otitis media but lower surgical procedures than non-Aboriginal children: A record linkage population-based cohort study |
Q33975684 | Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review |
Q33826419 | Bacterial profile of the oropharynx in infants: an assessment of the confounding factors for colonization. |
Q24650974 | Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response |
Q36650862 | Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial |
Q33734772 | Bronchiectasis in Children: Current Concepts in Immunology and Microbiology |
Q36504478 | Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in aboriginal infants with otitis media |
Q40262865 | Clear not simple: an approach to community consultation for a maternal pneumococcal vaccine trial among Indigenous women in the Northern Territory of Australia |
Q30482567 | Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial |
Q34951125 | Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation |
Q35175045 | Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children |
Q30951053 | Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data. |
Q41758945 | Determinants of non-healing ear discharge in chronic suppurative otitis media in a developing country |
Q38858432 | Diversity of nontypeable Haemophilus influenzae strains colonizing Australian Aboriginal and non-Aboriginal children. |
Q37354928 | Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a random |
Q33937355 | Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants |
Q33623151 | Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia |
Q33489894 | Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. |
Q41702335 | Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment |
Q33672446 | Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan |
Q85101852 | Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras |
Q33326481 | High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, |
Q44573237 | Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population |
Q60934657 | Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia |
Q39658011 | In vivo penicillin MIC drift to extremely high resistance in Serotype 14 Streptococcus pneumoniae persistently colonizing the nasopharynx of an infant with chronic suppurative lung disease: a case study |
Q40007556 | Long PCR-ribotyping of nontypeable Haemophilus influenzae |
Q33756778 | Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic. |
Q37790404 | Lower respiratory infections in Australian Indigenous children |
Q35042472 | Mailed versus frozen transport of nasal swabs for surveillance of respiratory bacteria in remote Indigenous communities in Australia |
Q37410062 | Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants |
Q46351719 | Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea |
Q33242986 | Measuring nasal bacterial load and its association with otitis media |
Q37028479 | Microbial interactions during upper respiratory tract infections |
Q39089108 | Microbiology of otitis media in Indigenous Australian children: review |
Q34571649 | Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract |
Q33949229 | Moraxella catarrhalis: a review of an important human mucosal pathogen |
Q92822414 | Nasal Delivery of a Commensal Pasteurellaceae Species Inhibits Nontypeable Haemophilus influenzae Colonization and Delays Onset of Otitis Media in Mice |
Q36164109 | Nasal carriage of common bacterial pathogens among healthy kindergarten children in Chaoshan region, southern China: a cross-sectional study |
Q34056142 | Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants |
Q40802365 | Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana |
Q37396978 | Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life |
Q35545863 | Nonencapsulated Haemophilus influenzae in Aboriginal infants with otitis media: prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer |
Q88290056 | Otitis media |
Q50498986 | Otitis media in Australian Aboriginal children: an overview. |
Q38173017 | Otitis media in Indigenous Australian children: review of epidemiology and risk factors. |
Q24813879 | Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey |
Q39933143 | Otitis media: viruses, bacteria, biofilms and vaccines. |
Q43172438 | Passive smoking and nasopharyngeal colonization by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in daycare children. |
Q42637748 | Pharyngeal colonization dynamics of Haemophilus influenzae and Haemophilus haemolyticus in healthy adult carriers |
Q40925246 | PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia. |
Q30487583 | Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial. |
Q33410695 | Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination |
Q37309210 | Population density profiles of nasopharyngeal carriage of 5 bacterial species in pre-school children measured using quantitative PCR offer potential insights into the dynamics of transmission |
Q91302046 | Preventative and medical treatment of ear disease in remote or resource-constrained environments |
Q34716929 | Prevention of otitis media by vaccination |
Q34433017 | Quantitative PCR of ear discharge from Indigenous Australian children with acute otitis media with perforation supports a role for Alloiococcus otitidis as a secondary pathogen |
Q34980321 | Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol |
Q54266987 | Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine. |
Q27002239 | Regulation of bacterial trafficking in the nasopharynx |
Q64449967 | Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla |
Q37094044 | Risk factors for otitis media and carriage of multiple strains of Haemophilus influenzae and Streptococcus pneumoniae |
Q34478996 | Risk factors for otitis media in children with special emphasis on the role of colonization with bacterial airway pathogens: the Generation R study |
Q39131974 | Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract |
Q37070354 | Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae |
Q34943748 | Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults |
Q35165999 | Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models |
Q39975708 | Successful application of a simple specimen transport method for the conduct of respiratory virus surveillance in remote Indigenous communities in Australia |
Q33384870 | Survival of pneumococcus on hands and fomites |
Q92652360 | The Impact of Hearing Impairment on the Life Trajectories of Aboriginal Children in Remote Australia: Protocol for the Hearing Loss in Kids Project |
Q45250733 | The Kalgoorlie Otitis Media Research Project: rationale, methods, population characteristics and ethical considerations |
Q36513457 | The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis |
Q24813429 | The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study |
Q39653881 | The extracytoplasmic sigma factor, final sigma(E), is required for intracellular survival of nontypeable Haemophilus influenzae in J774 macrophages |
Q36070189 | The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. |
Q39412949 | The nonserotypeable pneumococcus: phenotypic dynamics in the era of anticapsular vaccines |
Q26770238 | The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials |
Q58611300 | The unsolved problem of otitis media in indigenous populations: a systematic review of upper respiratory and middle ear microbiology in indigenous children with otitis media |
Q35506907 | Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial. |
Q49344691 | Transcriptional Modulation of Penicillin-Binding Protein 1b, Outer Membrane Protein P2 and Efflux Pump (AcrAB-TolC) during Heat Stress Is Correlated to Enhanced Bactericidal Action of Imipenem on Non-typeable Haemophilus influenzae |
Q49073915 | Turnover of Haemophilus influenzae isolates in otitis-prone children |
Q62899065 | Upper airway viruses and bacteria detection in clinical pneumonia in a population with high nasal colonisation do not relate to clinical signs |
Q34323552 | Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children |
Q92968776 | Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines |
Q31016790 | Viral-bacterial co-infection in Australian Indigenous children with acute otitis media |
Search more.